afamelanotide

FDA Drug Profile — SCENESSE

afamelanotide is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including SCENESSE. Available dosage form: implant.

Drug details

Generic Name
afamelanotide
Brand Names
SCENESSE
Application Number
NDA210797
Sponsor
CLINUVEL INC.
NDC Codes
2
Dosage Forms
IMPLANT
Routes
SUBCUTANEOUS
Active Ingredients
AFAMELANOTIDE

Indications and Usage

SCENESSE ® is indicated to increase pain free light exposure in adult patients with a history of phototoxic reactions from erythropoietic protoporphyria (EPP). SCENESSE is a melanocortin 1 receptor (MC1-R) agonist indicated to increase pain free light exposure in adult patients with a history of phototoxic reactions from erythropoietic protoporphyria (EPP)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.